These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15311109

  • 1. Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
    Brakch N, Abdel-Sayed S, Allemandou F, Wang Q, Aubert JF, Brunner HR, Nussberger J.
    J Hypertens; 2004 Sep; 22(9):1797-803. PubMed ID: 15311109
    [Abstract] [Full Text] [Related]

  • 2. Direct measurements of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alteration in salt-induced hypertension.
    Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M.
    Circulation; 1995 Feb 15; 91(4):1229-35. PubMed ID: 7850963
    [Abstract] [Full Text] [Related]

  • 3. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.
    Hypertension; 1999 Feb 15; 33(2):759-65. PubMed ID: 10024341
    [Abstract] [Full Text] [Related]

  • 4. Role of Brain Endothelin Receptor Type B (ETB) in the Regulation of Tyrosine Hydroxylase in the Olfactory Bulb of DOCA-Salt Hypertensive Rats.
    Cassinotti L, Guil M, Bianciotti L, Vatta M.
    Curr Vasc Pharmacol; 2023 Feb 15; 21(4):246-256. PubMed ID: 37349999
    [Abstract] [Full Text] [Related]

  • 5. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH, Venema RC, Pollock DM.
    Am J Physiol; 1998 Jul 15; 275(1):R245-52. PubMed ID: 9688985
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Renal damage is not improved by blockade of endothelin receptors in primary renin-dependent hypertension.
    Rothermund L, Kossmehl P, Neumayer HH, Paul M, Kreutz R.
    J Hypertens; 2003 Dec 15; 21(12):2389-97. PubMed ID: 14654760
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
    Hsieh TJ, Lin SR, Lee YJ, Shin SJ, Lai YH, Hsu CH, Tsai JH.
    Am J Physiol Renal Physiol; 2000 Jul 15; 279(1):F112-21. PubMed ID: 10894793
    [Abstract] [Full Text] [Related]

  • 11. Central endothelin ETB receptor activation reduces blood pressure and catecholaminergic activity in the olfactory bulb of deoxycorticosterone acetate-salt hypertensive rats.
    Guil MJ, Soria C, Seijas M, Bianciotti LG, Vatta MS.
    Eur J Pharmacol; 2020 Oct 15; 885():173543. PubMed ID: 32896551
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
    Pollock DM, Allcock GH, Krishnan A, Dayton BD, Pollock JS.
    Am J Physiol Renal Physiol; 2000 Feb 15; 278(2):F279-86. PubMed ID: 10662732
    [Abstract] [Full Text] [Related]

  • 13. Involvement of endothelins in deoxycorticosterone acetate-salt hypertension through the modulation of noradrenergic transmission in the rat posterior hypothalamus.
    Abramoff T, Guil MJ, Morales VP, Hope SI, Höcht C, Bianciotti LG, Vatta MS.
    Exp Physiol; 2015 Jun 15; 100(6):617-27. PubMed ID: 25809871
    [Abstract] [Full Text] [Related]

  • 14. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS, Turgeon A, Schiffrin EL.
    Am J Hypertens; 1998 May 15; 11(5):554-62. PubMed ID: 9633791
    [Abstract] [Full Text] [Related]

  • 15. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 May 15; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 16. Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.
    Giulumian AD, Molero MM, Reddy VB, Pollock JS, Pollock DM, Fuchs LC.
    Am J Physiol Heart Circ Physiol; 2002 May 15; 282(5):H1944-9. PubMed ID: 11959662
    [Abstract] [Full Text] [Related]

  • 17. Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.
    Molero MM, Giulumian AD, Reddy VB, Ludwig LM, Pollock JS, Pollock DM, Rusch NJ, Fuchs LC.
    J Hypertens; 2002 Sep 15; 20(9):1799-805. PubMed ID: 12195122
    [Abstract] [Full Text] [Related]

  • 18. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
    Larivière R, Sventek P, Thibault G, Schiffrin EL.
    Can J Physiol Pharmacol; 1995 Mar 15; 73(3):390-8. PubMed ID: 7544236
    [Abstract] [Full Text] [Related]

  • 19. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE, Tostes RC, Yogi A, Montezano AC, Touyz RM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):243-53. PubMed ID: 16271043
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
    Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, Chen AF.
    Circulation; 2003 Feb 25; 107(7):1053-8. PubMed ID: 12600921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.